Related policies are basically available、Supervision attitude is very clear，Pharmaceutical companies enter the countdown & ldquo; life and death arena & rdquo;。But，In addition to the pressure and time of capital investment、In addition to the task weight，Consistency Evaluation Work still has many difficulties，For example, the approval and compliance procurement of the reference preparation，and the scarcity of human biological equivalent test medical institutions，It is difficult to complete the family alone。

 

  Reporter learned from Shanghai Pharmaceutical Group Co., Ltd.，Shanghai Medical Group Co., Ltd. and Shanghai Jiaotong University School of Medicine, Ruijin Hospital、Huashan Hospital affiliated to Fudan University, such as Huashan Hospital, etc., a well -known Shanghai stake betting appHospital of Fudan University signed a drug clinical trial research strategic cooperation framework agreement。Future，They will carry out multiple cooperations，At present, 32 varieties of BE (biological equivalent) cooperation intention。

 

  Chen Yaoshui, deputy director of the Shanghai Food and Drug Administration，Shanghai is the & ldquo; cradle & rdquo;，It is also one of the areas with a lot of one -time evaluation.。But only 44 medical institutions with clinical experimental qualifications in Shanghai，Among them, there are only half of the human test that can do biological equivalent。Now the consistency evaluation time is tight、Mission weight，The price of a project is also rising.、Supply in short supply。This strategic cooperation，I hope to complement the resource of the hospital and the enterprise，Help stake sports betting appthe people choose best among medicine。

 

  Shou Ziqi, director of the Shanghai Science and Technology Commission, pointed out，Shanghai is creating a big life science center，Among them, we must give full play to resources and advantages，Focus on creating a specification、Have quality、Impact、The clinical center that really plays the role。& ldquo; Next will solidly promote cooperation，Promoting the energy level of the pharmaceutical industry & rdquo;。